MSKCC Fundamentals and Advances in Immunotherapy in the Oncology Patient 2023

Memorial Sloan Kettering Cancer Center Fundamentals and Advances in Immunotherapy in the Oncology Patient 2023

Format: 22 videos + 18 pdfs, size: 4.5 GB

Course Audience: physicians who care for oncology patients

Overview:

Date & Location

Tuesday, January 24, 2023, 7:50 AM – 5:00 PM, Online, New York , NY

Specialties

Specialties – Allergy and Immunology, Bone Marrow Transplant, Breast Medical Oncology, Cellular Therapeutics, Critical Care, Gastrointestinal Oncology, Genitourinary Oncology, Gynecologic Oncology, Head and Neck Oncology, Hospice and Palliative Medicine, Immunotherapy, Leukemia, Lymphoma, Medical Oncology, Neurology, Neuro-Oncology, Nurse Practitioner, Nursing, Oncology and Hematology, Pharmacology and Medication Management, Physician Assistant, Pulmonary Medicine, Radiation Oncology, Solid Tumor Oncology

Overview

Immunotherapeutics has changed the treatment modalities available to cancer patients in both solid tumors and hematologic malignancies. Since the breakthrough of ipilimumab, there have been fast-paced and ongoing advancements in the field of immunotherapy, revolutionizing clinical management rapidly.

This one-day live virtual course aims to improve cancer patient outcomes by advancing the science, development, and application of cancer immunology and immunotherapy through fundamental understanding and clinical application. Learners will review fundamental concepts and recent advances in immunotherapy designed to meet the learning needs of advanced practice providers (APPs) and other allied health professionals. Clinical application in solid tumor and hematologic malignancies will be discussed as well as toxicity management, including immune-related adverse events resulting from immune checkpoint inhibition. Experts will discuss the fundamentals of immune checkpoint blockade and CAR T cell therapy, as well as advancements in TIL and BITE therapy, novel combination therapy, and algorithmic management of immune-related adverse events. Toxicity management will be communicated through case study applications and demonstration of common, rare, and severe immune-related adverse events.

Who Should Attend

The target audience for this course includes nurse practitioners, physician assistants, certified registered nurse anesthetists, physicians, and nurses who care for oncology patients. We are pleased to offer complimentary registration for residents, fellows, APP students, and nursing students.

Objectives

1. Describe the principles surrounding the immunity cycle
2. Explain fundamental principles of immunotherapeutic agents including immune checkpoint inhibition, CAR T CELL , TIL, and BITE therapies.
3. Discuss clinical application of immune modulated agents in the oncology population
4. Discuss the symptoms of Cytokine release Syndrome and clinical management
5. Recognize and identify common, rare and severe immune related adverse events attributed to immune checkpoint inhibition

 

Algorithmic Management and Grading of Immune-Related Adverse Events (Video MP4 Format)

Algorithmic Management and Grading of Immune-Related Adverse Events (PDF Format)

APPImmunotherapy_2023_Brochure (PDF Format)

BITE and CAR T cell therapy in the Acute Leukemia Patient- A Case Study Approach (Video MP4 Format)

BITE and CAR T cell therapy in the Acute Leukemia Patient- A Case Study Approach (PDF Format)

Cardiac Immune-Related Adverse Event- Myocarditis (Video MP4 Format)

Cardiac Immune-Related Adverse Event- Myocarditis (PDF Format)

Clinical Application of Immune Checkpoint Inhibitors in Solid Tumor Malignancy Panel Discussion (Video MP4 Format)

Clinical Application of Immune Therapy in Hematologic Malignancy Panel Discussion (Video MP4 Format)

Clinical Considerations for Immune Checkpoint Toxicities Panel Discussion (Video MP4 Format)

Clinical Updates in Head and Neck Squamous Cell Carcinoma (Video MP4 Format)

Clinical Updates in Head and Neck Squamous Cell Carcinoma (PDF Format)

Clinical Updates in Lymphoma (Video MP4 Format)

Clinical Updates in Lymphoma (PDF Format)

Clinical Updates in Metastatic Breast Cancer (Video MP4 Format)

Clinical Updates in Metastatic Breast Cancer (PDF Format)

Clinical Updates in Myeloma (Video MP4 Format)

Clinical Updates in Myeloma (PDF Format)

Clinical Updates in Rectal Squamous Cell Carcinoma (Video MP4 Format)

Clinical Updates in Rectal Squamous Cell Carcinoma (PDF Format)

Clinical Updates in Sarcoma and Merkel Cell Carcinoma (Video MP4 Format)

Clinical Updates in Sarcoma and Merkel Cell Carcinoma (PDF Format)

Clnical Updates in Non-Small Cell Lung Cancer (Video MP4 Format)

Clnical Updates in Non-Small Cell Lung Cancer (PDF Format)

Cytokine Release Syndrome (Video MP4 Format)

Cytokine Release Syndrome (PDF Format)

Discussion of Novel Checkpoint Inhibitors and Combination Therapy (Video MP4 Format)

Discussion of Novel Checkpoint Inhibitors and Combination Therapy (PDF Format)

Fundamentals of Immune Checkpoint Blockade Panel Discussion (Video MP4 Format)

Fundamentals of T Cell Therapy Panel Discussion (Video MP4 Format)

Gastrointestinal Immune-Related Adverse Event- Colitis (Video MP4 Format)

Gastrointestinal Immune-Related Adverse Event- Colitis (PDF Format)

Mechanism of Action and Clinical Applications of Tumor Infiltrating Lymphocytic (TIL) Therapy (Video MP4 Format)

Mechanism of Action and Clinical Applications of Tumor Infiltrating Lymphocytic (TIL) Therapy (PDF Format)

Mechanism of Action of Checkpoint Blockade PD1, PDL1, CTLA-4 (Video MP4 Format)

Mechanism of Action of Checkpoint Blockade PD1, PDL1, CTLA-4 (PDF Format)

Neurological Immune-Related Adverse Event- Myasthenia Gravis (Video MP4 Format)

Neurological Immune-Related Adverse Event- Myasthenia Gravis (PDF Format)

Overview of Chimeric Antigen Receptor (CAR) T Cell Immunotherapy (Video MP4 Format)

Overview of Chimeric Antigen Receptor (CAR) T Cell Immunotherapy (PDF Format)